The Political Economy of Pharmaceutical Patents: US Sectional Interests and the African Group at the WTO (Routledge Global Health Series)

This book provides a fresh, multidisciplinary, and exciting look at the making and remaking of pharmaceutical patents at the GATT/WTO, by utilising a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin focuses on the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement and consequently, the role of the African Group at the WTO in the remaking of those patent provisions. Contents: Introduction Explaining 'who gets what' in international trade decision-making North/South controversies in the TRIPS negotiations: between hegemony and domination? Consensus formation in the TRIPS negotiations: agendas, agents and turning points Legitimacy and the TRIPS agreement: globalised law as 'consent without consent' The post-TRIPS context and the intensification of a contested terrain: the rise of the African Group (AG) at the WTO? Conclusion List of interviewees References Index. A fresh, multidisciplinary and exciting look at the making and remaking of pharmaceutical patents at the GAT/WTO, utilizing a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin addresses the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement, and consequently the role of the African Group at the WTO in the remaking of patent provisions